A Response to the FDA’s SSRI Panel Discussion

Syda Productions/Adobe Stock As a psychiatrist specialized in perinatal and infant mental health, I have seen…

FDA’s Elsa May Prompt Pharma To Rethink Regulatory Filings

By Pradeepta Mishra, VP, AI Innovation, Beghou Consulting For many years, pharmaceutical regulatory filings have been…